Prognostic Value of Tumor Markers in Gastric Cancer: A Tertiary Cancer Centre Experience

Objectives: Gastric cancer is a heterogeneous malignancy in terms of stage-wise prognosis. This study aimed at finding any prognostic significance of preoperative carcinoembryonic antigen (CEA) and cancer antigen (CA) 19-9 in resectable gastric cancer.Methods: A total of 57 patients at Kidwai Memorial Institute of Oncology, Bengaluru, India from January 2022 to March 2023 were included in this observational prospective study. Included patients had a resectable tumor at clinical staging. Patients were divided into two categories (raised and non-raised) based on serum tumor marker (CEA and CA 19-9) levels. Their relationship with clinicopathological features was studied. The association was studied using chi-square test, and p-value <0.05 was considered significant.Results: The mean age of the study group was 55.47 years with male predominance (63.2%, n=36). Raised CEA and CA 19-9 were seen in 15.8% (n=9) and 10.5% (n=6) patients, respectively, while both markers were raised in 5.3% (n=3). Raised CEA was found significantly associated with grade 3 adenocarcinoma stomach (OR 7.825, 95%CI: 1.374-44.562; p = 0.020) and intraoperative finding of inoperability due to occult intraabdominal disease (p<0.05). CA 19-9 (pre-and post-operative levels) had no statistically significant association (p>0.05) with the grade of adenocarcinoma.Conclusion: This study indicates a benefit in estimating CEA for the prediction of prognosis in gastric cancer. CEA levels have been found to predict chances of finding occult intra-abdominal metastasis in gastric cancer.

Automated summary

This study aimed to investigate the prognostic significance of preoperative carcinoembryonic antigen (CEA) and cancer antigen (CA) 19-9 in resectable gastric cancer. The results showed that CEA levels can predict prognosis and are associated with the grade of adenocarcinoma of the stomach and occult intra-abdominal metastasis in gastric cancer. CA 19-9 levels were not significantly associated with the grade of adenocarcinoma.